BRKR Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) today reported financial results for the first quarter ended March 31, 2010.

Q1 GAAP Highlights

         

Q1-2010

         

Q1-2009

         

Growth

Revenue

         

$

277.7M

         

$

230.5M

         

+20.5%

Operating Income

$

26.9M

$

14.3M

+88.1%

EPS

$

0.10

$

0.05

+100%

Financial Results

In the first quarter of 2010, Bruker’s revenue was $277.7 million, an increase of 20.5% compared to revenue of $230.5 in the first quarter of 2009. Excluding the effects of foreign currency translation, first quarter 2010 revenue increased by 12.4% year-over-year. In the first quarter of 2010, GAAP revenue increased by 16.4% year-over-year for the Bruker Scientific Instruments (BSI) segment, and by 156% year-over-year for the Bruker Energy & Supercon Technologies (BEST) segment.

Bruker’s operating income in the first quarter of 2010 was $26.9 million, compared to $14.3 million in the first quarter of 2009. GAAP operating margin for the BSI segment in the first quarter of 2010 was 10.6%, compared to 7.2% in the first quarter of 2009.

Bruker’s GAAP net income for the first quarter of 2010 was $16.1 million, or $0.10 per diluted share, compared to net income of $8.4 million, or $0.05 per diluted share, in the first quarter of 2009. Included in Bruker’s earnings per share (EPS) for the first quarter 2010 was non-cash stock-based compensation expense of ($0.01) per diluted share, the same as in the first quarter of 2009. EPS for the BSI segment in the first quarter of 2010 was $0.10, compared to $0.06 in the first quarter of 2009. EPS for the first quarter of 2010 for the BEST segment was $0.00, compared to a loss of ($0.02) in the first quarter of 2009.

Bruker cash flow from operations for the first quarter 2010 was $5.5 million, compared to $13.1 million in the first quarter of 2009. Bruker ended the first quarter of 2010 with cash, cash equivalents and restricted cash of $206.6 million, and net cash of $73.4 million.

Comment and Outlook

Frank Laukien, President and CEO, commented: “We are very pleased with our first quarter 2010 results, with strong year-over-year revenue growth and significant improvements in gross and operating margins. All four operating divisions in our BSI segment delivered double-digit growth year-over-year, and our BEST segment had triple-digit growth for the second quarter in a row. The industrial and applied markets continued to improve gradually during the first quarter, and overall we recorded healthy new order bookings, including more than $10 million in additional U.S. stimulus orders, all of which contributed to strong backlog at the end of the first quarter.”

EARNINGS CONFERENCE CALL

Bruker Corporation will host an operator-assisted earnings conference call at 9:00 a.m. Eastern Daylight Time on Thursday, April 29, 2010. To listen to the webcast, investors can go to http://ir.bruker.com and click on the live web broadcast symbol. The webcast will be available through the Company web site for 30 days. Investors can also listen and participate on the telephone in the US and Canada by calling 800-688-0796, or +1-617-614-4070 outside the US and Canada. Investors should refer to the Bruker Earnings Call. A telephone replay of the conference call will be available one hour after the conference call by dialing 888-286-8010 in the US and Canada, or +1-617-801-6888 outside the US and Canada, and then entering replay pass code 62891829. For more information, please visit http://ir.bruker.com.

CAUTIONARY STATEMENT

Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, risks and uncertainties relating to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the future, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, realization of anticipated benefits from economic stimulus programs, intellectual property rights, litigation, and exposure to foreign currency fluctuations and other risk factors discussed from time to time in our filings with the Securities and Exchange Commission. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2009, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We expressly disclaim any intent or obligation to update these forward-looking statements other than as required by law.

 

Bruker Corporation

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

(in millions, except per share data)

      Three Months Ended March 31,   2010     2009   Product revenue $ 244.0 $ 202.2 Service revenue 31.5 26.9 Other revenue   2.2     1.4 Total revenue 277.7 230.5   Cost of product revenue 134.2 111.7 Cost of service revenue   17.2     16.1 Total cost of revenue   151.4     127.8   Gross profit 126.3 102.7   Operating Expenses: Sales and marketing 49.1 42.6 General and administrative 17.0 16.3 Research and development 32.8 29.1 Restructuring and acquisition-related charges   0.5     0.4 Total operating expenses   99.4     88.4   Operating income 26.9 14.3   Interest and other income (expense), net   (0.3 )   0.1   Income before income taxes and noncontrolling interest in consolidated subsidiaries 26.6 14.4 Income tax provision   10.6     5.8   Consolidated net income 16.0 8.6 Net income (loss) attributable to noncontrolling interests in consolidated subsidiaries   (0.1 )   0.2 Net income attributable to Bruker Corporation $ 16.1   $ 8.4   Net income per common share attributable to Bruker Corporation shareholders: Basic and diluted $ 0.10   $ 0.05   Weighted average common shares outstanding: Basic   164.1     163.3 Diluted   165.6     164.3  

Bruker Corporation

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

(in millions)

        March 31, December 31,   2010   2009   ASSETS

 

Current assets: Cash, cash equivalents and restricted cash $ 206.6 $ 209.1 Accounts receivable, net 174.9 184.1 Inventories 431.2 422.8 Other current assets   61.6   57.5 Total current assets 874.3 873.5   Property, plant and equipment, net 212.0 223.4 Intangible and other long-term assets   73.3   75.1   Total assets $ 1,159.6 $ 1,172.0   LIABILITIES AND SHAREHOLDERS' EQUITY   Current liabilities: Short-term borrowings $ 23.6 $ 22.0 Accounts payable 53.7 49.8 Customer advances 218.3 219.2 Other current liabilities   248.4   249.2 Total current liabilities 544.0 540.2   Long-term debt 109.6 114.6 Other long-term liabilities 88.1 98.4   Total shareholders' equity   417.9   418.8   Total liabilities and shareholders' equity $ 1,159.6 $ 1,172.0  

Reconciliation of BSI and BEST reportable segments to the consolidated results of Bruker

Corporation for the quarters ended March 31, 2010 and 2009 (unaudited)

(in millions, except per share data)

        Bruker Bruker Energy & Corporate, Consolidated Scientific Supercon Adjustments Bruker March 31, 2010: Instruments Technologies & Eliminations Corporation   Revenue $ 260.3 $ 20.7 $ (3.3 ) $ 277.7   Gross profit 122.5 4.1 (0.3 ) 126.3 Gross profit margin 47.1 % 19.8 % 45.5 %   Operating income (loss) 27.7 (0.5 ) (0.3 ) 26.9 Operating margin 10.6 % (2.4 %) 9.7 %   Net income (loss) attributable to Bruker Corporation 17.2 (0.8 ) (0.3 ) 16.1   Diluted net income (loss) per common share attributable to Bruker Corporation $ 0.10 $ (0.00 ) $ 0.10   Weighted average shares outstanding: 165.6 164.1 165.6                     March 31, 2009:   Revenue $ 223.6 $ 8.1 $ (1.2 ) $ 230.5   Gross profit 101.4 0.7 0.6 102.7 Gross profit margin 45.3 % 8.6 % 44.6 %   Operating income (loss) 16.1 (2.4 ) 0.6 14.3 Operating margin 7.2 % (29.6 %) 6.2 %   Net income (loss) attributable to Bruker Corporation 10.2 (2.6 ) 0.8 8.4   Diluted net income (loss) per common share attributable to Bruker Corporation $ 0.06 $ (0.02 ) $ 0.05   Weighted average shares outstanding: 164.3 163.3 164.3